Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes (Q44136555)

30 November 2017

Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes (English)

1 reference

30 November 2017

1 reference

4

1 reference

30 November 2017

5

1 reference

30 November 2017

Enrico Sanna

1

1 reference

30 November 2017

Fabio Busonero

2

1 reference

30 November 2017

Giuseppe Talani

3

1 reference

30 November 2017

Michela Peis

6

1 reference

30 November 2017

Elisabetta Maciocco

7

1 reference

30 November 2017

Giovanni Biggio

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

European Journal of Pharmacology

30 November 2017

1 reference

30 November 2017

451

1 reference

30 November 2017

2

1 reference

30 November 2017

103-110

1 reference

The effects of single doses of CL284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Mechanism of action of the hypnotic zolpidem in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Molecular targets for the myorelaxant action of diazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Molecular and neuronal substrate for the selective attenuation of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Which GABAA-receptor subtypes really occur in the brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

A new benzodiazepine pharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Binding of [3H]CB 34, a selective ligand for peripheral benzodiazepine receptors, to rat brain membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Affinity of various ligands for GABAA receptors containing alpha 4 beta 3 gamma 2, alpha 4 gamma 2, or alpha 1 beta 3 gamma 2 subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

2-Phenyl-imidazo[1,2-a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

Novel 2-phenylimidazo[1,2-a]pyridine derivatives as potent and selective ligands for peripheral benzodiazepine receptors: synthesis, binding affinity, and in vivo studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice. Evaluation of benzodiazepine-related agonists and partial agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902191-X

10.1016/S0014-2999(02)02191-X

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference